[ALA] YoY Quarter Result on 31-Dec-2017 [#Q2]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Dec-2017
Financial Year
2018
Quarter
31-Dec-2017 [#Q2]
Profit Trend
QoQ- 0.00%
YoY- -136.31%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 243 370 427 202 195 1,419 1,523 -26.33%
PBT -1,756 -7,699 -435 -1,113 -527 -906 -979 10.21%
Tax -9 0 0 0 56 0 -6 6.98%
NP -1,747 -7,699 -435 -1,113 -471 -906 -972 10.25%
Tax Rate - - - - - - - -
Total Cost 1,990 8,069 862 1,315 666 2,325 2,495 -3.69%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -720.44 -2,081.94 -101.83 -551.87 -240.94 -63.82 -63.87 49.70%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.01 -0.05 -0.00 -0.02 -0.01 -0.02 -0.03 -16.71%
EPS Diluted -0.01 -0.05 -0.00 -0.02 -0.01 -0.02 -0.02 -10.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.